Literature DB >> 15925551

Cisplatin induces DNA double-strand break formation in Escherichia coli dam mutants.

Anetta Nowosielska1, M G Marinus.   

Abstract

Escherichia coli dam cells are more susceptible to the cytotoxic action of cisplatin than wildtype. Dam mutS or dam mutL bacteria, however, are resistant to this agent indicating that active mismatch repair sensitizes dam cells to cisplatin toxicity. Genetic data, obtained previously, were consistent with the generation and repair of cisplatin-induced double-strand breaks (DSBs). We measured DSB formation in temperature-sensitive dam recB mutants, after exposure to cisplatin, using pulse field gel electrophoresis and observed an increase in linear 100-300 kb DNA fragments corresponding to approximately 15-45 double strand breaks per genome. The formation of these DSBs was temperature and dose-dependent and was decreased in recBC bacteria at the permissive temperature or in dam(+) or mutS control strains. There was a three-fold increase in circa 2 mb linear chromosomal fragments in dam recBC strains at the non-permissive temperature compared to recBC alone. We show that dam priA strains are not viable suggesting that DSB formation is dependent on DNA replication restart. The sensitivity of priA mutants to cisplatin is also consistent with this conclusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925551     DOI: 10.1016/j.dnarep.2005.03.006

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  30 in total

1.  Dam methyltransferase is required for stable lysogeny of the Shiga toxin (Stx2)-encoding bacteriophage 933W of enterohemorrhagic Escherichia coli O157:H7.

Authors:  Kenan C Murphy; Jennifer M Ritchie; Matthew K Waldor; Anders Løbner-Olesen; M G Marinus
Journal:  J Bacteriol       Date:  2007-11-02       Impact factor: 3.490

2.  Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.

Authors:  Pang-ning Teng; Nicholas W Bateman; Kathleen M Darcy; Chad A Hamilton; George Larry Maxwell; Christopher J Bakkenist; Thomas P Conrads
Journal:  Gynecol Oncol       Date:  2015-01-02       Impact factor: 5.482

3.  Determination of hypersensitivity to genotoxic agents among Escherichia coli single gene knockout mutants.

Authors:  Elinne Becket; Frank Chen; Cindy Tamae; Jeffrey H Miller
Journal:  DNA Repair (Amst)       Date:  2010-07-31

4.  Differential effects of cisplatin and MNNG on dna mutants of Escherichia coli.

Authors:  Melissa A Calmann; M G Marinus
Journal:  Mutat Res       Date:  2005-10-15       Impact factor: 2.433

5.  Repair of DNA damage induced by bile salts in Salmonella enterica.

Authors:  Ana I Prieto; Francisco Ramos-Morales; Josep Casadesús
Journal:  Genetics       Date:  2006-08-03       Impact factor: 4.562

6.  Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers.

Authors:  Ting Luo; Jianqing Yu; Jenny Nguyen; Chun-Rong Wang; Robert G Bristow; David A Jaffray; Xiao Zhen Zhou; Kun Ping Lu; Qing-Bin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-08       Impact factor: 11.205

7.  Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients.

Authors:  E Castro; D Olmos; A Garcia; J J Cruz; R González-Sarmiento
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

8.  Analysis of global gene expression and double-strand-break formation in DNA adenine methyltransferase- and mismatch repair-deficient Escherichia coli.

Authors:  Jennifer L Robbins-Manke; Zoran Z Zdraveski; Martin Marinus; John M Essigmann
Journal:  J Bacteriol       Date:  2005-10       Impact factor: 3.490

9.  DNA mismatch repair-induced double-strand breaks.

Authors:  Anetta Nowosielska; M G Marinus
Journal:  DNA Repair (Amst)       Date:  2007-09-10

10.  Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.

Authors:  Cui-Jie Shao; Jun Fu; Hong-Liu Shi; Yong-Gao Mu; Zhong-Ping Chen
Journal:  J Neurooncol       Date:  2008-04-16       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.